This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biogen Idec Becomes First U.S.-Based Biotech Named To Dow Jones Sustainability World Index

Stocks in this article: BIIB

Biogen Idec (NASDAQ: BIIB) today announced that it has been added to the prestigious Dow Jones Sustainability World Index (DJSI World) – becoming the first and only U.S. based biotech sector firm to make the list. The company was also named to the Dow Jones Sustainability Index (DJSI) North America for the fourth consecutive year, one of only three biotech companies included.

Additionally, the Carbon Disclosure Project (CDP) released the results of its Annual Investor Survey, awarding Biogen Idec the top Carbon Disclosure Score for the biotech sector, and in the top 10 overall in the broader, highly-competitive Healthcare category. The CDP is an international non-profit organization focused on assessing the business risks and opportunities from the environmental impact disclosure data of thousands of the world’s largest companies. Biogen Idec significantly improved its score from the prior year, demonstrating a high degree of transparency regarding its carbon footprint and the company’s continued focus on being a more sustainable organization globally.

“Biogen Idec has put great focus on citizenship and environmental sustainability, directly incorporating them into our business activities and making them a cultural imperative across our organization,” said George Scangos, chief executive officer of Biogen Idec. “These accomplishments are a testament to the commitment of our more than 6,000 employees worldwide to exemplify high standards and create economic, social and environmental value for our company and our stakeholders.”

Only 333 companies worldwide were named to the DJSI World in 2013, a report that tracks the performance of the 2,500 largest companies in the S&P Global Broad Market Index SM. Biogen Idec’s overall DJSI score was significantly above the industry average and represented an improvement over the year prior -- even as the overall industry average dropped. The company scored in the 100 th percentile for its industry on 10 specific social, environmental and economic dimensions including: corporate citizenship and philanthropy, talent attraction and retention, occupational health and safety, and operational eco-efficiency.

Biogen Idec publishes an annual Corporate Citizenship Report based on internationally recognized Global Reporting Initiative Guidelines. In its most recent report, the company announced that it had achieved its goal of reducing its overall environmental footprint by 15 percent in 2012, several years ahead of schedule. The company also reported on its efforts to engage its employees in improving the lives of patients and in the communities where it operates.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit:

Copyright Business Wire 2010

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,900.32 +95.52 0.54%
S&P 500 2,071.46 +0.81 0.04%
NASDAQ 4,771.4890 +6.1090 0.13%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs